Bleeding and other outcome measures
bleeding, neurological deterioration
ADVERSE EVENTS, BLEEDING, RECURRENCE
The severity of bleeding was assessed on a five level ordered categorical scaleFurther safety outcomes included all-cause and cause-specific case fatality, early neurological deterioration (defined as an increase from baseline to day 7 of at least 4 points on the NIHSS and/or a reduction in consciousness in the NIHSS consciousness domain), and serious adverse events.The primary efficacy outcome was measured at 90 days and comprised stroke/TIA recurrence and its severity; severity was assessed using a six-level ordinal scale